The Economic Burden of Acute Coronary Syndromes for Employees and Their Dependents

Authors:
  • VGVahram Ghushchyan
    Vahram Ghushchyan
  • BGBrian Gifford
    Brian Gifford
  • RRRichard Allen Read
    Richard Allen Read
  • MRMonika Raut
    Monika Raut
  • CCConcetta Crivera
    Concetta Crivera
  • ANAhmad B. Naim
    Ahmad B. Naim
  • CDC.V. Damaraju
    C.V. Damaraju
  • KNKavita V. Nair
    Kavita V. Nair

Abstract
To determine the total burden of illness, including direct and indirect costs for employees and their dependents with acute coronary syndrome (ACS). Medical and pharmacy claims along with short-term disability (STD) and long-term disability (LTD) claims from 2007 to 2010 were analyzed using two data sets: Integrated Benefits Institute's Health and Productivity Benchmarking Database (STD and LTD claims) and IMS LifeLink™ Health Plan Data (medical and pharmacy claims). Employees with ACS lost 60.2 ± 0.29 STD and 397.9 ± 8.09 LTD days per disability incident. For employers, the estimated average per claim productivity loss from STD and LTD was $7943 ± 39.7 and $52,473 ± 1114, respectively. Total annual ACS health care costs per employee were $8170 ± 106, with $7545 ± 104 for annual medical costs. Hospitalizations accounted for 75% of total annual ACS health care costs. ACS imposes a substantial economic burden on employees, employers, and society.

This publication has 20 references indexed in Scilit: